Wordt geladen...
Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations
Pharmacoproteomics is the study of disease-modifying and toxicity parameters associated with therapeutic drug administration, using analysis of quantitative and temporal changes to specific, predetermined, and select proteins, or to the proteome as a whole. Pharmacoproteomics is a rapidly evolving f...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5343982/ https://ncbi.nlm.nih.gov/pubmed/28218733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18020448 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|